BTC Health (ASX:BTC) Margin of Safety % (DCF Dividends Based): N/A (As of Jun. 30, 2026)


What is BTC Health Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

BTC Health's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Dividends Based) is not calculated.

ASX:BTC vs VRTX, REGN, ALNY: Margin of Safety % (DCF Dividends Based) Comparison

For the Biotechnology subindustry, BTC Health's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BTC Health Margin of Safety % (DCF Dividends Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BTC Health's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where BTC Health's Margin of Safety % (DCF Dividends Based) falls into.


BTC Health Business Description

Address 10 Oxley Road, Level 1, Hawthorn, Melbourne, VIC, AUS, 3122
BTC Health Ltd is a pooled development fund focused on seeking new investment opportunities in entities operating in the biotechnology and life sciences sectors. Its sole operating segment involves making and managing healthcare ventures. The company's products include Elasto-Q, Rythmic Infusion Pumps, Tiva, Infusion and Nerve Catheter Kits, Biopsy Needles, Radiological Markers, Rebellion Bone Removal System, Bonopty Coaxial Bone Biopsy, ECLS (Extracorporeal Life Support) Oxygenators, Pears, Valves, NEOLA, and LPS Adsorber. Geographically, it operates in Australia.